Inventor · disambiguated record
Thomas A. Miller
Also filed as: MILLER THOMAS · MILLER THOMAS A · MILLER THOMAS ALAN · MILLER THOMAS C
28 granted patents·15 pending applications·664 citations·filing 1982–2020
97Inventor score
Top patents by PatentIndex Score
43 records- 0198US6511990B1Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Jan 28, 2003·213 cites·35 claims
- 0296US7851509B2Polymorphs of suberoylanilide hydroxamic acidMERCK HDAC RES LLC·Filed 2008·Granted Dec 14, 2010·20 cites·43 claims
- 0395US7732490B2Methods of treating cancerMERCK HDAC RES LLC·Filed 2007·Granted Jun 8, 2010·50 cites·74 claims
- 0495US7375137B2Methods of treating cancer with HDAC inhibitorsMERCK HDAC RES LLC·Filed 2006·Granted May 20, 2008·27 cites·56 claims
- 0594US7652069B2Polymorphs of suberoylanilide hydroxamic acidMERCK HDAC RES LLC·Filed 2007·Granted Jan 26, 2010·11 cites·84 claims
- 0691US4668666ALong-acting pyrethrum/pyrethroid based pesticides with silicone stabilizersADAMS VETERINARY RES LAB·Filed 1984·Granted May 26, 1987·46 cites·39 claims
- 0790US7399787B2Methods of treating cancer with HDAC inhibitorsMERCK HDAC RES LLC·Filed 2003·Granted Jul 15, 2008·32 cites·11 claims
- 0889US11110338B1Ski binding with heelless telemark couplingMILLER THOMAS ALAN·Filed 2020·Granted Sep 7, 2021·5 cites·19 claims
- 0988US8101663B2Polymorphs of suberoylanilide hydroxamic acidMILLER THOMAS A·Filed 2009·Granted Jan 24, 2012·4 cites·13 claims
- 1088US7456219B2Polymorphs of suberoylanilide hydroxamic acidMERCK HDAC RES LLC·Filed 2003·Granted Nov 25, 2008·17 cites·43 claims
- 1188US7345174B2Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofSLOAN KETTERING INST CANCER·Filed 2006·Granted Mar 18, 2008·6 cites·9 claims
- 1288US7126001B2Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereofUNIV COLUMBIA·Filed 2002·Granted Oct 24, 2006·16 cites·11 claims
- 1387US7847122B2Polymorphs of suberoylanilide hydroxamic acidMERCK HDAC RES LLC·Filed 2008·Granted Dec 7, 2010·4 cites·9 claims
- 1486US7148257B2Methods of treating mesothelioma with suberoylanilide hydroxamic acidSLOAN KETTERING INST CANCER·Filed 2003·Granted Dec 12, 2006·19 cites·55 claims
- 1584US5439924ASystemic control of parasitesVIRBAC INC·Filed 1994·Granted Aug 8, 1995·69 cites·37 claims
- 1682US8067472B2Methods of treating Hodgkin's and non-Hodgkin's lymphomaRICHON VICTORIA M·Filed 2010·Granted Nov 29, 2011·7 cites·4 claims
- 1781US5632999ASustained release pyriproxifen compositions for parasite controlVIRBAC INC·Filed 1993·Granted May 27, 1997·24 cites·30 claims
- 1878US5747057ASustained release pyriproxifen compositions for parasite controlVIRBAC INC·Filed 1996·Granted May 5, 1998·21 cites·15 claims
- 1977US8227636B2Histone deacetylase inhibitor prodrugsMILLER THOMAS A·Filed 2005·Granted Jul 24, 2012·3 cites·30 claims
- 2077US7199134B2Hydroxamic acid compounds and methods of use thereofUNIV COLUMBIA·Filed 2004·Granted Apr 3, 2007·8 cites·38 claims
- 2175US6518064B1Pink bollworm expression system for commercially valuable protein productionUNIV CALIFORNIA·Filed 2000·Granted Feb 11, 2003·6 cites·14 claims
- 2269US8450372B2Formulations of suberoylanilide hydroxamic acid and methods for producing sameWONG JEANNIE CHOW·Filed 2010·Granted May 28, 2013·2 cites·61 claims
- 2368US4467086ACephalosporin antibioticGLAXO GROUP LTD·Filed 1982·Granted Aug 21, 1984·7 cites·1 claims
- 2467US5013733ALactam derivativesGLAXO GROUP LTD·Filed 1990·Granted May 7, 1991·23 cites·9 claims
- 2564US5728719ASystemic control of parasitesVIRBAC INC·Filed 1995·Granted Mar 17, 1998·24 cites·35 claims
- 2659US7799803B2Hydroxamic acid compounds and methods of use thereofUNIV COLUMBIA·Filed 2007·Granted Sep 21, 2010·0 cites·10 claims
- 2759US2008114069A1Methods of inducing terminal differentiationRICHON VICTORIA M·Filed 2007·Application pending·0 cites
- 2857US2008249179A1Methods of treating cancer with HDAC inhibitorsBACOPOULOS NICHOLAS G·Filed 2007·Application pending·0 cites
- 2955US2008227862A1Methods of treating cancer with HDAC inhibitorsRICHON VICTORIA M·Filed 2007·Application pending·0 cites
- 3055US2004127523A1Methods of treating cancer with HDAC inhibitorsFiled 2003·Application pending·0 cites
- 3154US2012041067A1Methods of Inducing Terminal DifferentiationRICHON VICTORIA M·Filed 2011·Application pending·0 cites
- 3254US2007060614A1Methods of treating cancer with hdac inhibitorsBACOPOULOS NICHOLAS G·Filed 2004·Application pending·0 cites
- 3353US2006276547A1Methods of treating cancer with HDAC inhibitorsBACOPOULOS NICHOLAS G·Filed 2006·Application pending·0 cites
- 3452US2004132825A1Methods of treating cancer with HDAC inhibitorsFiled 2003·Application pending·0 cites
- 3552US2007190022A1Combination methods of treating cancerBACOPOULOS NICHOLAS G·Filed 2004·Application pending·0 cites
- 3649US2003086952A1Highhly concentrated emulsions of organic compounds and methos of useFiled 2002·Application pending·0 cites
- 3748US7935724B2Thiophene and benzothiophene hydroxamic acid derivativesMERCK HDAC RES LLC·Filed 2004·Granted May 3, 2011·0 cites·17 claims
- 3848US2009012175A1Methods of treating cancer with HDAC inhibitorsBACOPOULOS NICHOLAS G·Filed 2008·Application pending·0 cites
- 3944US2003040436A1Use of benzyl ester compositions for controlling non-arthropod pest populationsFiled 2001·Application pending·0 cites
- 4043US2010273732A1Combination methods of treating cancerBACOPOULOS NICHOLAS G·Filed 2010·Application pending·0 cites
- 4141US2009023718A1Diamine and Iminodiacetic Acid Hydroxamic Acid DerivativesATON PHARMA INC·Filed 2004·Application pending·0 cites
- 4240US2005074901A1Methods and assays for detecting and quantifying the human p53 inducible gene proteinFiled 2003·Application pending·0 cites
- 4329US6175014B1Process for the preparation of lactam derivativesGLAXO GROUP LTD·Filed 1993·Granted Jan 16, 2001·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Thomas A. Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →